COCP (Cocrystal Pharma, Inc.) חוב לטווח קצר להון
This daily price chart for Cocrystal Pharma, Inc. (COCP) on the GURU.Markets platform, where the indicator stands at 0.25, is supported by a stable staff of dedicated scientists, which minimizes personnel turnover. The business is based on innovative crystallography for the synthesis of potent molecules in US laboratories. The company's strategy focuses on creating a broad spectrum of drugs targeting various viral strains, which significantly reduces overall regulatory risks.
פילוחים אנליטיים של חברת Cocrystal Pharma, Inc.
The ratio determines the share of short-term liabilities within the equity structure, measuring the company's liquidity dependence on external debt financing. Analyzing the shift in the ratio between short-term borrowed capital and equity allows for an assessment of the balance between financial stability and R&D expenditures, which is critical for Cocrystal Pharma, Inc. (COCP) when conducting costly clinical trials of antiviral drugs.